• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET UK LTD. BIOLOX DELTA MODULAR CERAMIC FEM HD 28/-3MM T1; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET UK LTD. BIOLOX DELTA MODULAR CERAMIC FEM HD 28/-3MM T1; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER Back to Search Results
Model Number N/A
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Code Joint Impingement (4834)
Date of Event 05/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: cat# 110024462 lot# 65693056 or lot# 65698952, g7 dual mobility liner 40mm d, cat# ep-200146 lot# 65690347 act artic e1 hip brg 28x40mm, cat# 010000702 lot# 7335542 or lot# 7216410, g7 bonemaster ltd acet shl 50d.G2: foreign: australia the device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported the patient underwent an initial hip procedure.Subsequently, the patient was revised approximately one year later due to joint impingement.Attempts have been made and no further information has been provided.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.No product was returned or pictures provided.Visual and dimensional evaluations could not be performed.A review of the device manufacturing records confirmed, no abnormalities or deviations.Based on the available information, the reported event cannot be confirmed.A definitive root cause could not be determined.However, as the surgeon performed the revision surgery to implant a new shell replacing the one at orientation thirty-one inclination and fourty-three anteversion, to one at orientation thirty-nine inclination twenty-nine anteversion.It is likely, that the initial shell orientation was the main factor.If any further information is found, which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOLOX DELTA MODULAR CERAMIC FEM HD 28/-3MM T1
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER
Manufacturer (Section D)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK  CF31 3XA
Manufacturer (Section G)
.
waterton industrial estates
bridgend CF31 3XA
UK   CF31 3XA
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key19379766
Report Number3002806535-2024-00186
Device Sequence Number20764640
Product Code LZO
UDI-Device Identifier00887868271533
UDI-Public(01)00887868271533(17)320412(10)3111506
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K192683
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberN/A
Device Catalogue Number650-1159
Device Lot Number3111506
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/01/2024
Supplement Date Received by Manufacturer07/09/2024
Initial Report FDA Received Date05/23/2024
Supplement Report FDA Received Date07/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/12/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-